This application claims the benefits of the Taiwan Patent Application Serial NO. 101125285 filed on Jul. 13, 2012, the subject matter of which is incorporated herein by reference.
1. Field of the Invention
The present invention relates to a method for manufacturing drugs, more particularly to a method for manufacturing drugs, in which Ludwigia octovalvis is used as raw material and which enhance brain function and delay neurodegradation.
2. Description of the Prior Art
As global population tends to get older in age, a majority of the population suffers from Alzheimer's disease such that several countries are attending to this problem with a great concern. According to a research, an estimation of approximately more than 24 millions people suffers from this disease all over the world. In case a patient suffering from this disease gets worse, he or she needs the help from nearby persons in all aspects of life, such as bathing, eating, going to the toilet and so on. Since the patient with Alzheimer's disease needs to be taken care of day in and day out, family members and the patient's relatives and friends are often encountered with a great deal of inconveniences and discomfort in their daily lives.
So far, there is still no accurate diagnosis and effective treatment for Alzheimer's disease, and therefore the scientists all over are working hard and conducting researches in order to develop a new drug for treating this disease.
Therefore, the inventor of the present invention believes that it is urgently needed to develop a new method for manufacturing drugs that can effectively boost or enhance brain function and delay neurodegradation in people, more particularly in the elder people.
As above mentioned, in the prior art technique, there is no clear or effective method of treating Alzheimer's disease, and in order to find other treatments or drugs, the inventor of the present application has recently developed a drug to enhance brain function and delay neurodegradation method for producing the drugs.
An experiment conducted according to the present invention provides a method for manufacturing drugs to enhance brain function and delay neurodegeneration, the drugs or medicines accordingly produced can improve brain function, and can delay neurodegeneration.
The method of the present invention for manufacturing drugs that enhance brain function, wherein Ludwigia octovalvis is used as raw material, the method includes the steps of: dip a predetermined amount of Ludwigia octovalvis in a first extraction solution to extract a first Ludwigia octovalvis extraction solution and a Ludwigia octovalvis residue; separate the Ludwigia octovalvis residue from the first Ludwigia octovalvis extraction solution; and conduct a drying process to the first Ludwigia octovalvis extraction solution to obtain an extracted Ludwigia octovalvis substance.
Preferably, after the drying process, the method of the present invention further includes a step, where the extracted Ludwigia octovalvis substance is redissolved in the first extraction solution in such a manner that the extracted Ludwigia octovalvis substance has a concentration ranging between 0.0005% ˜0.5%.
In the manufacturing method of the present invention, the predetermined amount of Ludwigia octovalvis is dipped in the first extraction solution for 4˜12 hours. Preferably, the predetermined amount of Ludwigia octovalvis is dipped in the first extraction solution at a low temperature ranging 2˜10° C. In addition, after the predetermined amount of Ludwigia octovalvis is dipped in the first extraction solution for 4˜12 hours, and then first the extraction solution is heated for 10˜60 minutes.
In the manufacturing method of the present invention further includes a substep, where the Ludwigia octovalvis residue is dipped in a second extraction solution, after which the second extraction solution is heated and filtered in such a manner to extract a second Ludwigia octovalvis extraction solution, which, in turn, is combined with the first Ludwigia octovalvis extraction solution.
Preferably, the manufacturing method of the present invention further includes a step, wherein the predetermined amount of Ludwigia octovalvis is ground prior to dipping (the same) in the first extraction solution.
The manufacturing method of the present invention further includes a step, wherein separating the Ludwigia octovalvis residue from the first Ludwigia octovalvis extraction solution is conducted via centrifugal filtering means.
Preferably, the manufacturing method of the present invention further includes in one step, wherein after the predetermined amount of Ludwigia octovalvis is dipped in the first extraction solution, the first extraction solution is heated at a temperature ranging from 50˜100° C. In addition, the drying process in one of the step is a freeze drying process.
In the manufacturing method of the present invention an alcohol solution serves as the first extraction solution. Preferably, after dipping the predetermined amount of Ludwigia octovalvis in the first extraction solution, the first extraction solution is heated indirectly through a water bath up to a temperature ranging from 50˜100° C. Moreover, the drying process in one of the step is a decompress concentration process.
The advantages provided by the manufacturing method of the present invention are as follows.
From above mentioned paragraphs, it is obvious that so far no Ludwigia octovalvis is ever used as raw material for manufacturing the drugs that enhance brain function and that delay neurodegradation.
In addition, since the Ludwigia octovalvis serves as the raw material and since the same is easily found in botanical plants, the manufacturing cost can be reduced to manufacture the drugs with the manufacturing method of the present invention.
Other features and advantages of this invention will become more apparent in the following detailed description of the preferred embodiments of this invention, with reference to the accompanying drawings, in which:
The method of the present invention for manufacturing drugs, which enhance brain function and delay neurodegradation and in which Ludwigia octovalvis is used as raw material. Since the manufacturing steps differ from one another, the following paragraphs only illustrate an example for better understand of the present invention; however the scope of the present invention should not be limited to those given in the examples.
In this embodiment, since the predetermined amount of Ludwigia octovalvis is ground first of all, and then is dipped in the first extraction solution so that extraction work relative to the first Ludwigia octovalvis extraction solution is effective and the extraction time is shortened. The first extraction solution is selected from a nontoxic but edible and fine stable solutions, such as a water-solvent solution and an alcohol solution, such that during the extraction process of the first Ludwigia octovalvis extraction solution and the extraction of the Ludwigia octovalvis residue, there is no chemical reactions and the extraction can he carried out in a stable manner. In addition, when the alcohol solution is chosen as the first extraction solution, the first extraction solution is heated indirectly through a water bath.
In the step S120, centrifugal filtering means is conducted in order to separate the Ludwigia octovalvis residue from the first Ludwigia octovalvis extraction solution.
Afterwards in the step S130, the Ludwigia octovalvis residue (separated from the first Ludwigia octovalvis extraction solution) is dipped in a second extraction solution, after which the second extraction solution is heated at the temperature ranging 50° C.˜100° C. for 10˜60 minutes and centrifugal filtering means is conducted in order to filter in such a manner to extract a second Ludwigia octovalvis extraction solution, which, in turn, is combined with the first Ludwigia octovalvis extraction solution.
In the step S140, conduct a drying process to the first Ludwigia octovalvis extraction solution so as to obtain an extracted Ludwigia octovalvis substance. In the event, the first extracted solution is water solvent, a freeze drying process is conducted in order to obtain the extracted Ludwigia octovalvis substance. In the event, the alcohol solution is chosen as the first extracted solution is, a decompress concentration process is conducted to the first Ludwigia octovalvis extraction solution so as to obtain the extracted Ludwigia octovalvis substance.
Finally in the step S150, the extracted Ludwigia octovalvis substance is redissolved in the first Ludwigia octovalvis extraction solution in such a manner that the extracted Ludwigia octovalvis substance has a concentration ranging between 0.0005%˜0.5%.
Firstly, the (a) group is fed on edible food containing the extracted Ludwigia octovalvis substance with concentration of 0.005%; the (b) group is fed on edible food containing the extracted Ludwigia octovalvis substance with concentration of 0.01%; the (c) group is fed on edible food containing the extracted Ludwigia octovalvis substance with concentration of 0.1% while the (d) group is fed on edible food without containing the extracted Ludwigia octovalvis substance. In this experiment, the edible food contains 2˜20% sugar, 2˜20% yeast powder and 0.5˜2% agar and different concentration of the extracted Ludwigia octovalvis substance.
The survival rate of the (a), (b), (c) and (d) groups is recorded after every two days. As shown in the graph, fruit flies belonging to the groups (a), (b) and (c) survive longer when compared the flies belonging to the group (d). Hence, this experiment, proves that those fruit flies fed on edible food containing the extracted Ludwigia octovalvis substance have high survival rate (longer lifespan).
It is noted that , from the 20th day to the 40th day, the male flies belonging to the group (c) (concentration of 0.1%) have a higher survival rate, and after the 40th day onward, the male flies belonging to the group) (a) (concentration of 0.005%) and the group (b) (concentration of 0.01%) respectively have higher survival rate. In short, though the male flies belonging to the group (b) from the 20th day to the 40th day have a lower survival rate than the group (c), the male flies of the group (b) have a higher survival rate after the 40th day onward when compared to the group (e).
To conduct the “Pavlovian Olfactory Associative Learning” test, fruit flies are maintained under an environment of 25° C. and are fed on edible food containing 0%, 0.005%, 0.01% and 0.1% of the extracted Ludwigia octovalvis substance. The test is then carried out at 20 days of age.
In this test, two different odors; i.e., 3-OCT (3-Octanol) and 4-MCH (4 -Methylcyclohexanol), which respectively have a ratio of 1.5:1000 and 1:1000 in mineral oil. Both 3-OCT and 4-MCH odors are disliked by fruit flies. The whole test is conducted in the darkroom.
The first step is exposing the fruit flies to 3-OCT for 60 seconds, during which, an electroshock (strength for 70 volts) is applied for 1.5 seconds and 3.5 seconds of rest in an alternate manner. Immediately after 45 seconds of resting, the fruit flies are subsequently exposed to 4-MCH for 60 seconds without application of electroshock (3-OCT and 4-MCH can be exchanged alternately). The fruit flies are then allowed to rest for 30 seconds. Finally, the fruit flies are allowed to enter a T-maze with 3-OCT and 4-MCH provided at two opposing arms of the T-maze for a period of two minutes. The performance index or memory index is calculated by subtracting the number of the fruit flies entering the 3-OCT arm from those entering the 4-MCH arm, and then dividing by the total number of the fruit flies and is multiplied by 100%.
In the second step of the test, the odor paired with electroshock are exchanged and the test is carried out as described above. The average memory index is obtained by balancing the two results.
In
SMAP8 mice treated with 0 or 0.01% of the extracted Ludwigia octovalvis substance are placed in an box (20×20×10 inches). During the training period, two different training objects are placed within the box, and mice are allowed to explore the two training objects for 5 minutes. After a period of time (1 hr or 2 hrs), one of the training objects is replaced by a new object and the mice are allowed to freely explore for another 5 minutes. The time mice spend on new object, and the old object are recorded. The object recognition index is compiled by dividing the spent time for exploring the old object, or a new object with the total time for exploring the old object and the new object. The result achieved thereby is multiplied by 100%.
SMAP8 mice are bred and treated with 0 and 0.01% of the extracted Ludwigia octovalvis substance as described in
From the above experiment, 24 hours after the training, mice treated with 0.01% of the extracted Ludwigia octovalvis substance show better memory performance on the elevated T-maze task, as they remain in the closed space for a longer period of time compared to mice treated with 0% of the extracted Ludwigia octovalvis substance.
For those persons having general knowledge in the technical field, by reading this invention should understand the following features:
(i) Since the Ludwigia octovalvis is dipped in the extraction solution at low temperature, the extraction solution soaks through the Ludwigia octovalvis in such a manner to extract a Ludwigia octovalvis extraction solution and a Ludwigia octovalvis residue. In addition, the Ludwigia octovalvis is ground prior to the dipping operation, extraction of Ludwigia octovalvis substance is effective, and heating of the extraction solution facilitates and enhances extraction of the Ludwigia octovalvis substance.
(ii) Since a drying process is conducted to the Ludwigia octovalvis extraction solution, the extracted Ludwigia octovalvis substance thus can be obtained at a higher concentration, the drugs produced accordingly enhance the brain functions and delay neurodegneration.
While the invention has been described in connection with what is considered the most practical and preferred embodiments, it is understood that this invention is not limited to the disclosed embodiments but is intended to cover various arrangements included within the spirit and scope of the broadest interpretation so as to encompass all such modifications and equivalent arrangements.
Number | Date | Country | Kind |
---|---|---|---|
101125285 | Jul 2012 | TW | national |